Brain cancer module: QLQ-BN Scope. The brain cancer module is meant for use among brain cancer patients varying in disease stage and treatment. The EORTC QLQ-BN20 questionnaire for assessing the health-related quality of life (HRQoL) in brain cancer patients: A phase IV validation. To be used in conjunction with the EORTC QLQ-C30 for measuring the health- related quality of life in patients with brain cancer.
|Published (Last):||9 December 2012|
|PDF File Size:||6.62 Mb|
|ePub File Size:||1.27 Mb|
|Price:||Free* [*Free Regsitration Required]|
Distribution-based approaches hinge on the statistical features of the HRQoL data. Separate analyses were conducted for these two anchors. Further investigation, if possible with other anchors, is therefore recommended. Benchmarks for interpreting differences between groups cross-sectionally may differ from those for interpreting changes over time within groups [ 2 ]. Translation and pilot validation of Hindi translation of assessing quality of life eorct patients with primary brain tumours using EORTC brain qlq-bb20 BN These anchors are clearly definable, understandable, and are commonly used by clinicians in assessment qq-bn20 cancer patients and could therefore help guide interpretation of HRQoL scores.
Related articles in Web of Science Google Scholar. Content validation of the FACT-Br with patients and health care professionals to assess quality of life in patients with brain metastases. Van Den Bent, R. Prosthetics and Orthotics International.
EORTC QLQ-BN20 – EORTC Quality of Life Questionnaire – Brain Cancer Module
Giant-cell arteritis without cranial manifestations presenting as fever alq-bn20 unknown origin: Table 5 presents distribution-based MCID estimates for comparison with anchor-based estimates in Tables 3 and 4. How to cite this URL: Changes in PS are accepted as clinically significant by most oncologists, and PS criteria is frequently used to determine eligibility for a given treatment or clinical trial.
There were major suggestions in three questions, which were incorporated into the second intermediate questionnaire to form the final Hindi BN questionnaire. The two versions differ only in the response options for items eoortc the physical and role functioning domains. Claudia BitterlichDirk Vordermark Oncology letters Quality of life of breast cancer patients elrtc Taiwan: Patients classified as having improved by the anchor tended to have better HRQoL scores, and those classified as deteriorated by the anchor tended to have worse HRQoL scores, while those classified as not changed by the anchor generally did not appear to have changed in their HRQoL i.
Determining the minimal clinically important difference MCID [ 1 ] for HRQoL scores from cancer clinical trials is useful eeortc clinicians, patients, and researchers as a benchmark for assessing the effectiveness of a health care intervention and for determining the sample size in a clinical trial.
Since the results for T 1 and T 2 were very similar, only the results at T 1 are reported. Close mobile search navigation Elrtc navigation.
Table 1 summarizes selected baseline demographic and clinical characteristics in the combined sample of all the patients from the two trials. These 2 questionnaires were then compared with the original EORTC questionnaire and the second intermediate questionnaire was formed.
References Publications referenced by this paper.
EORTC Quality of Life Questionnaire – Brain Cancer Module (EORTC QLQ-BN20)
A threshold of 0. A combination of qlqq-bn20 and anchor-based approaches determined minimally important differences MIDs for four endpoints in a breast cancer scale. Furthermore, it has not yet been established whether the same thresholds apply to improvement and deterioration in HRQoL scores.
To further clarify the issue of MCIDs, the findings from the anchor-based approach were compared with selected distribution-based techniques. Using a variety of clinical classifications as anchors, King [ 14 ] came to similar findings after collating results from various studies and various cancer sites. Q 1 and Q 3 are the lower and upper quartiles.
Showing of 3 extracted citations. For permissions, please email: Furthermore, as more and more studies examine the MCIDs for differing questionnaires and cancers, it will become evident whether it is possible to qlq-vn20 and adopt one MCID or a set of MCIDs for all questionnaires qlq-bn02 patient groups.
Investigators have relied on two distinct approaches for identifying the MCID: How to cite qlq-bb20 article: Quality, interpretation and presentation of European Organization for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomized controlled trials.
Oxford University Press is a department of the University of Oxford.